Current management for the disease often rely on shots of GLP-1 receptor activators, a procedure that can be burdensome for patients. Researchers are actively developing innovative administration methods to optimize individual adherence and outcomes. These include by mouth formulations, nasal delivery, and even long-acting devices, providing a redu

New Evidence Shows 22.8% Weight Loss in Long-term Study The SURMOUNT-4 trial has shown remarkable results for eco-friendly weight management. Our analysis of this landmark study reveals that participants lost an impressive 25.3% of their weight with tirzepatide, whereas the placebo group achieved only 9.9%. Maintaining weight loss has always bee